Advertisement
ATRC vs TMCI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a StrongBuy and TMCI is a Hold.
ATRC's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for ATRC turned positive on October 23, 2026. Looking at past instances where ATRC's MACD turned positive, the stock continued to rise in 38 of 46 cases over the following month. The odds of a continued upward trend are 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on ATRC as a result. In 62 of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
Following a +1.60% 3-day Advance, the price is estimated to grow further. Considering data from situations where ATRC advanced for three days, in 215 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
ATRC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 157 of 222 cases where ATRC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
Bearish Trend Analysis
The 10-day RSI Indicator for ATRC moved out of overbought territory on September 25, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 23 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 77%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ATRC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 35 (best 1 - 100 worst), indicating steady price growth. ATRC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.808) is normal, around the industry mean (4.989). ATRC's P/E Ratio (268.045) is considerably higher than the industry average of (37.210). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (4.869) is also within normal values, averaging (56.876).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATRC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
TMCI in downward trend: 10-day moving average broke below 50-day moving average on October 01, 2026
The 10-day moving average for TMCI crossed bearishly below the 50-day moving average on October 01, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
TMCI moved below its 50-day moving average on September 30, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMCI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for TMCI entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TMCI's RSI Indicator exited the oversold zone, 31 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on TMCI as a result. In 70 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for TMCI just turned positive on October 21, 2026. Looking at past instances where TMCI's MACD turned positive, the stock continued to rise in 31 of 43 cases over the following month. The odds of a continued upward trend are 72%.
Following a +5.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMCI advanced for three days, in 204 of 268 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
TMCI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.100) is normal, around the industry mean (2.906). P/E Ratio (-4.641) is within average values for comparable stocks, (2.003). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.430) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. TMCI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 41 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TMCI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
ATRC | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 88 | |
PRICE GROWTH RATING 1..100 | 35 | |
P/E GROWTH RATING 1..100 | 7 | |
SEASONALITY SCORE 1..100 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ATRC | TMCI | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 77% | 3 days ago 74% |
| Stochastic ODDS (%) | 3 days ago 71% | 3 days ago 85% |
| Momentum ODDS (%) | 3 days ago 77% | 3 days ago 77% |
| MACD ODDS (%) | 3 days ago 83% | 3 days ago 72% |
| TrendWeek ODDS (%) | 3 days ago 72% | 3 days ago 77% |
| TrendMonth ODDS (%) | 3 days ago 82% | 3 days ago 86% |
| Advances ODDS (%) | 11 days ago 71% | 4 days ago 76% |
| Declines ODDS (%) | 7 days ago 83% | 18 days ago 86% |
| BollingerBands ODDS (%) | 3 days ago 77% | 3 days ago 88% |
| Aroon ODDS (%) | 3 days ago 71% | 3 days ago 89% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ATRC’s FA Score shows that 1 FA rating(s) are green while TMCI’s FA Score has 1 green FA rating(s).
- ATRC’s FA Score: 1 green, 4 red.
- TMCI’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ATRC’s TA Score shows that 5 TA indicator(s) are bullish while TMCI’s TA Score has 5 bullish TA indicator(s).
- ATRC’s TA Score: 5 bullish, 3 bearish.
- TMCI’s TA Score: 5 bullish, 5 bearish.
Price Growth
ATRC (@Pharmaceuticals: Other) experienced а +5.17% price change this week, while TMCI (@Medical/Nursing Services) price change was +10.34% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.78%. For the same industry, the average monthly price growth was -3.41%, and the average quarterly price growth was +7.38%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.51%. For the same industry, the average monthly price growth was -9.72%, and the average quarterly price growth was -10.64%.
Reported Earning Dates
ATRC is expected to report earnings on Nov 03, 2026.
TMCI is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+2.78% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-0.51% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MFMO | 21.67 | 0.30 | +1.41% |
| Motley Fool Momentum Factor ETF (MFMO) | |||
| CMDY | 64.24 | 0.46 | +0.72% |
| iShares Bloomberg Roll Select Commodity Strategy ETF (CMDY) | |||
| TYLD | 25.42 | 0.04 | +0.14% |
| Cambria Tactical Yield ETF (TYLD) | |||
| DFMC | 57.84 | -0.20 | -0.34% |
| U.S. Micro Cap Portfolio ETF (DFMC) | |||
| SCZ | 82.45 | -0.44 | -0.53% |
| iShares MSCI EAFE Small-Cap ETF (SCZ) | |||
ATRC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with CERS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then CERS could also see price increases.
| Ticker / NAME | Correlation To ATRC | 1D Price Change % | ||
|---|---|---|---|---|
| ATRC | 100% | -0.56% | ||
| CERS - ATRC | 42% Loosely correlated | +0.87% | ||
| SIBN - ATRC | 41% Loosely correlated | -0.37% | ||
| IRMD - ATRC | 38% Loosely correlated | -2.08% | ||
| TMCI - ATRC | 37% Loosely correlated | -0.23% | ||
| MXCT - ATRC | 37% Loosely correlated | -2.10% | ||
More | ||||